Haloperidol Injection
- Packing: 1 Ml Ampoule.
- Available Strength : 5 Mg/Ml
Description
Product Description: Haloperidol Injection is a pharmaceutical solution containing haloperidol, a potent antipsychotic medication belonging to the butyrophenone class. It is formulated for parenteral administration to provide rapid and effective control of psychotic symptoms. Manufactured to the highest quality standards, Haloperidol Injection offers essential support for managing various psychiatric disorders.
Indications and Usage: Haloperidol Injection is indicated for the management of schizophrenia and acute psychotic episodes. It is also used for the control of severe behavioral disturbances and agitation in patients with delirium or dementia. Additionally, it may be employed as an adjunctive therapy in the treatment of Tourette's syndrome and severe behavioral disorders in children.
Dosage and Administration: The dosage of Haloperidol Injection varies depending on the patient's age, weight, and clinical condition. It is typically administered via intramuscular or intravenous injection under the supervision of a healthcare professional. The initial dose and subsequent dosing regimen should be individualized based on the patient's response and tolerance to therapy.
Dosage Forms and Strengths: Haloperidol Injection is available as a sterile solution in vials containing specific concentrations of haloperidol formulated for parenteral administration. Each vial is carefully manufactured to ensure accurate dosing and optimal therapeutic outcomes.
Contraindications: This product is contraindicated in patients with a known hypersensitivity to haloperidol or any of the excipients. It should not be used in patients with severe central nervous system depression or comatose states. Additionally, it is contraindicated in patients with Parkinson's disease or a history of neuroleptic malignant syndrome.
Warnings and Precautions: Healthcare providers should exercise caution when administering Haloperidol Injection to elderly patients, as they may be more susceptible to adverse effects, such as extrapyramidal symptoms and sedation. Patients should be monitored regularly for signs of neuroleptic malignant syndrome, tardive dyskinesia, and other movement disorders. Long-term use of haloperidol may increase the risk of metabolic side effects, including weight gain, hyperglycemia, and dyslipidemia.
Adverse Reactions/Side Effects: Common adverse reactions associated with Haloperidol Injection include extrapyramidal symptoms (e.g., dystonia, akathisia, parkinsonism), sedation, and anticholinergic effects (e.g., dry mouth, constipation, urinary retention). Cardiovascular side effects, such as orthostatic hypotension and QT prolongation, may also occur. Rarely, hypersensitivity reactions, including rash, angioedema, and anaphylaxis, may occur. Patients should be advised to report any unusual symptoms promptly.
Drug Interactions: Haloperidol may interact with a wide range of medications, including other antipsychotic drugs, central nervous system depressants, and medications that prolong the QT interval. Healthcare providers should review the patient's medication profile carefully to identify potential drug interactions and adjust dosage as necessary to minimize risks.
Use In Specific Populations Description: Safety and efficacy of Haloperidol Injection in pediatric patients, pregnant women, and nursing mothers have not been established conclusively. Healthcare providers should assess the potential risks and benefits before prescribing this medication in these populations.
How Supplied/Storage and Handling: Haloperidol Injection is supplied as a sterile solution in vials for intramuscular or intravenous injection. It should be stored at controlled room temperature (20°C to 25°C) away from light and moisture. Care should be taken to ensure proper storage and handling to maintain the integrity of the product. Unused portions should be discarded according to standard procedures for biohazardous waste.
